Skip to content

Cadd Solis Vip Ambulatory Infusion Pump and Cadd Solis Medication Safety Software

by Smiths Medical Asd, Inc.

510(k) K111275

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

5 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK111275 Date1 Feb 2013ClearedStatusActive

Recalls

6 recalls · 5 ongoing · FDA

    • Ongoing Z-1682-2025 FDA Class I initiated 10 Apr 2025

    There is a potential for thermal damage in CADD-Solis and CADD- Solis VIP infusion pumps.

    • Ongoing Z-1668-2025 FDA Class I initiated 10 Apr 2025

    Affected pumps may trigger an erroneous (false) Upstream Occlusion Alarm under certain conditions, which will interrupt an active infusion. Interruption or delay of therapy can lead to serious patient injury or death.

    • Ongoing Z-0222-2025 FDA Class I initiated 16 Jul 2024

    Damage to the battery pack may have caused a short to a capacitor within the battery pack. While the battery encasement is designed to be flame retardant, a short to the capacitor could lead to melting of the battery pack case. If this issue occurs, the battery pack charging circuit may become inoperable.

    • Ongoing Z-0466-2025 FDA Class II initiated 26 Jun 2024 on shared 510(k) K111275

    The adapter input plug can become damaged or broken. If the input plug is damaged, the metal contacts to the body of the AC adapter may be exposed or one or more of the AC mains prongs may separate from the input plug.

    • Ongoing Z-2421-2024 FDA Class I initiated 27 Feb 2024

    The CADD Solis VIP Ambulatory Infusion Pump is indicated for the following uses: " For intravenous, intraarterial, subcutaneous, intraperitoneal, perineural, surgical site, epidural space, or subarachnoid space infusion.

    • Terminated Z-0107-2022 FDA Class I initiated 24 Mar 2020

    Specific Pumps may exhibit intermittent performance in the AILD (Air in Line Detector) function. If an AILD does not sufficiently discern fluid from air in line, an air in line event may not be recognized by the pump and may not alarm to notify the clinician.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FRN
Device Class
Class II
Regulation
21 CFR Part 880.5725
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Smiths Medical Asd, Inc.

See all devices from Smiths Medical Asd, Inc. →